SethPLernerMD

PubMed

• Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial.
  Sumanta K Pal, Petros Grivas, Shilpa Gupta, Nazli Dizman, Zeynep Zengin, Begona P Valderrama, Alejo Rodriguez-Vida, Florian Roghmann, Elena Sevillano Fernandez, Surena...> ;European Urology. 2024 Apr 4
• Multiomics profiling of urothelial carcinomareveals CIS-specific gene signature and immune characteristics.
  Meenakshi Anurag, Trine Strandgaard, Sung Han Kim, Yongchao Dou, Eva Comperat, Hikmat Al-Ahmadie, Brant A Inman, Ann Taber, Iver Nordentoft, Jørgen Bjerggaard Jensen, ...> ;Iscience. 2024 Mar 15
• The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
  Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongc...> ;Nature Communications. 2024 Feb 14
• 1 citations
  Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial Carcinoma.
  Abhishek Tripathi, Seth P Lerner> ;JCO Precision Oncology. 2023 Aug 1
• 1 citations
  Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).
  Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, David James McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Ri...> ;European Urology. 2023 Sep 1
• Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
  Kyle M Rose, Heather L Huelster, Joshua J Meeks, Bishoy M Faltas, Guru P Sonpavde, Seth P Lerner, Jeffrey S Ross, Philippe E Spiess, G Daniel Grass, Rohit K Jain, Ashi...> ;Nature Reviews. Urology. 2023 Jul 1
• 45 citations
  Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors.
  Ibrahim Jubber, Sean Ong, Laura Bukavina, Peter C Black, Eva Compérat, Ashish M Kamat, Lambertus Kiemeney, Nathan Lawrentschuk, Seth P Lerner, Joshua J Meeks, Holger M...> ;European Urology. 2023 Aug 1
• 10 citations
  Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
  Yi-Tsung Lu, Melissa Plets, Gareth Morrison, Alexander T Cunha, Steven Y Cen, Suhn K Rhie, Kimberly D Siegmund, Siamak Daneshmand, David I Quinn, Joshua J Meeks, Seth ...> ;European Urology Oncology. 2023 Oct 1
• 8 citations
  Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
  Kyle M Rose, Heather L Huelster, Joshua J Meeks, Guru P Sonpavde, Seth P Lerner, Jeffrey S Ross, Philippe E Spiess, G Daniel Grass, Rohit K Jain, Ashish M Kamat, Aram ...> ;Nature Reviews. Urology. 2023 Jul 1
• 4 citations
  Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review.
  Luca Antonelli, Kirby Sebro, Abdelilah Lahmar, Peter C Black, Saum Ghodoussipour, Jill M Hamilton-Reeves, Jay Shah, Jensen Bente Thoft, Seth Paul Lerner, Carlos Lloren...> ;European Urology Focus. 2023 Jul 1
• Evolving the surgical approach for bladder cancer - robotic versus open radical cystectomy.
  Sagar R Patel, Seth P Lerner> ;Nature Reviews. Urology. 2023 Apr 1
• 2 citations
  Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model.
  Hugo Villanueva, Gabrielle A Wells, Malachi T Miller, Mariana Villanueva, Ravi Pathak, Patricia Castro, Michael M Ittmann, Andrew G Sikora, Seth P Lerner> ;Heliyon. 2022 Dec 1
• Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors.
  Sung Han Kim, Seth P Lerner> ;Journal of Clinical Oncology. 2023 Jan 10
• Drug instillation in the management of urinary tract urothelial carcinoma.
  Sung Han Kim, Seth P Lerner> ;Current Opinion in Urology. 2022 Sep 1
• 28 citations
  International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladde...
  Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, Seth P Lerner, Wassim Kassouf, Andreas Böhle, Maurizio Brausi, Roger Buckley, Raj Persad, Marc Colombel, Donal...> ;European Urology. 2022 Jul 1
• 10 citations
  Targetingalterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial.
  Sumanta K Pal, Diederik M Somford, Petros Grivas, Srikala S Sridhar, Shilpa Gupta, Joaquim Bellmunt, Guru Sonpavde, Mark T Fleming, Seth P Lerner, Yohann Loriot, Jean ...> ;Future Oncology. 2022 Jul 1
• 24 citations
  Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial ...
  Surena F Matin, Phillip M Pierorazio, Nir Kleinmann, John L Gore, Ahmad Shabsigh, Brian Hu, Karim Chamie, Guilherme Godoy, Scott G Hubosky, Marcelino Rivera, Michael O...> ;The Journal of Urology. 2022 Apr 1
• Reply by Authors.
  Surena F Matin, Phillip M Pierorazio, Nir Kleinmann, John L Gore, Ahmad Shabsigh, Brian Hu, Karim Chamie, Guilherme Godoy, Scott G Hubosky, Marcelino Rivera, Michael O...> ;The Journal of Urology. 2022 Apr 1
• 6 citations
  Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of...
  Anirban P Mitra, Vikram M Narayan, Sharada Mokkapati, Tanner Miest, Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore, Leonard G Gomella, Ashis...> ;European Urology. 2022 Mar 1
• Re: Identification of Differential Tumor Subtypes of T1 Bladder Cancer.
  Sagar R. Patel, Seth P. Lerner> ;European Urology. 2021 Nov 16
• 6 citations
  Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Adv...
  Elaine Chang, Andrea B. Apolo, Rick Bangs, Stephanie Chisolm, Vinay Duddalwar, Jason A. Efstathiou, Kirsten B. Goldberg, Donna E. Hansel, Ashish M. Kamat, Paul G. Klue...> ;Nature Reviews. Urology. 2021 Sep 10
• 3 citations
  Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
  Hyun Hwan Sung, Douglas S. Scherr, Joel W. Slaton, Hao Liu, Katy Ledford Feeny, Colleen A. Lingley-Papadopoulos, John Gearheart, Jason M. Zara, Seth P. Lerner> ;Urologic Oncology. 2021 Apr 29
• 1 citations
  Novel Thermo-Sensitive Hydrogel Therapy for Low-Grade Upper Tract Urothelial Carcinoma
  Sagar R. Patel, Seth P. Lerner> ;The Journal of Urology. 2021 Mar 31
• 6 citations
  Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
  Ahmad Shabsigh, Nir Kleinmann, Angela B. Smith, Douglas S. Scherr, Elyse Seltzer, Mark P. Schoenberg, Seth P. Lerner> ;Cancer Chemotherapy and Pharmacology. 2021 Mar 7
• 7 citations
  Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.
  Adam S. Feldman, Girish S. Kulkarni, Trinity J. Bivalacqua, Peter C. Black, Scott E. Delacroix, Seth P. Lerner, Ashish M. Kamat, Wassim Kassouf> ;Urologic Oncology. 2021 Feb 25
• Join now to see all